Severe Osteomalacia in an Adult HIV Patient on Tenofovir Disoproxil Fumarate. [PDF]
Machiraju S +3 more
europepmc +1 more source
Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switch. [PDF]
Zeng ZH, Liu JQ, Zhang M, Qiu CL, Xu ZY.
europepmc +1 more source
Tenofovir disoproxil fumarate: safe and effective option for managing high-viral-load chronic hepatitis B. [PDF]
Song W, Bao J.
europepmc +1 more source
Efficacy and Safety of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide Fumarate in Treating Acute-on-Chronic Liver Failure with Hepatitis B Virus: A Network Meta-analysis. [PDF]
Liu J, Bi Y, Ma X, Xin Y.
europepmc +1 more source
Comparison of efficacy and safety of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate treatment in patients with high viral load of hepatitis B virus. [PDF]
Zhang C +6 more
europepmc +1 more source
Economic evaluation of HIV-exposure Prophylaxis among men-who have sex with men in England: Supplementary material [PDF]
van Hoek, AJ
core
Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study. [PDF]
Mugwanya KK +25 more
europepmc +1 more source
Weight gain on tenofovir alafenamide fumarate-based therapy compared to tenofovir disoproxil fumarate- and abacavir-based therapy in children and young people living with HIV in Europe. [PDF]
European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group.
europepmc +1 more source
The benefits and risks of PrEP and kidney function. [PDF]
Mocroft, A, Ryom, L
core +1 more source
Long-term metabolic and safety profiles of tenofovir alafenamide and tenofovir disoproxil fumarate in ART-naive people living with HIV: a multicenter retrospective study using a mixed-effects model. [PDF]
Karabay O +21 more
europepmc +1 more source

